Inhibition of ribosomal protein RPS6KB1 as a strategy to improve conventional therapy for prostate cancer

被引：0
|
作者：
Clark, Alison D. [1 ]
Hussain, Suleman S. [2 ]
Huang, Shih-Bo [1 ]
Bedolla, Roble G. [1 ]
Obeidat, Mohammad A. [1 ]
Papanikolaou, Niko [1 ]
Lin, Chun Lin [1 ]
Huang, Tim H. [1 ]
Gupta, Yogesh [1 ]
Chen, Yidong [1 ]
Miyamoto, Hiroshi [3 ]
Ghosh, Rita [1 ]
Kumar, Addanki P. [1 ]
机构：
[1] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
[2] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[3] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-3943
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3943
引用
收藏
页数：2
相关论文
共 50 条
  • [1] INHIBITION OF RPS6KB1 AS A POTENTIAL ADJUVANT FOR PROSTATE CANCER RADIATION THERAPY
    Hussain, Suleman
    Bedolla, Roble
    Miyamoto, Hiroshi
    Rivas, Paul
    Basler, Joseph
    Swanson, Gregory
    Papanikolaou, Nikos
    Reddick, Robert
    Ghosh, Rita
    Kumar, Addanki
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1171 - E1171
  • [2] Suppression of ribosomal protein RPS6KB1 by Nexrutine increases sensitivity of prostate tumors to radiation
    Hussain, Suleman S.
    Huang, Shih-Bo
    Bedolla, Roble G.
    Rivas, Paul
    Basler, Joseph W.
    Swanson, Gregory P.
    Huang, Tim Hui-Ming
    Narayanasamy, Ganesh
    Papanikolaou, Nikos
    Miyamoto, Hiroshi
    Yeh, I-Tien
    Reddick, Robert L.
    Pollock, Brad H.
    Ghosh, Rita
    Kumar, Addanki P.
    CANCER LETTERS, 2018, 433 : 232 - 241
  • [3] p70 Ribosomal protein S6 kinase (Rps6kb1): an update
    Bahrami-B, Farnaz
    Ataie-Kachoie, Parvin
    Pourgholami, Mohammad H.
    Morris, David L.
    JOURNAL OF CLINICAL PATHOLOGY, 2014, 67 (12) : 1019 - 1025
  • [4] Inhibition of AURKA targets gastrointestinal cancer cells with activated KRAS by inhibiting RPS6KB1
    Chen, Zheng
    Bishop, Lihong W.
    Gomaa, Ahmed
    Lockhart, Albert C.
    Salaria, Safia
    Ecsedy, Jeffrey
    Washington, Kay
    Beauchamp, Robert D.
    El-Rifai, Wael
    CANCER RESEARCH, 2019, 79 (13)
  • [5] miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer
    Cai, Chao
    Chen, Qing-Biao
    Han, Zhao-Dong
    Zhang, Yan-Qiong
    He, Hui-Chan
    Chen, Jia-Hong
    Chen, Yan-Ru
    Yang, Sheng-Bang
    Wu, Yong-Ding
    Zeng, Yan-Ru
    Qin, Guo-Qiang
    Liang, Yu-Xiang
    Dai, Qi-Shan
    Jiang, Fu-Neng
    Wu, Shu-lin
    Zeng, Guo-Hua
    Zhong, Wei-De
    Wu, Chin-Lee
    CLINICAL CANCER RESEARCH, 2015, 21 (21) : 4922 - 4934
  • [6] Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer
    Slattery, Martha L.
    Lundgreen, Abbie
    Herrick, Jennifer S.
    Wolff, Roger K.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2011, 706 (1-2) : 13 - 20
  • [7] Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1
    Wang-Bishop, Lihong
    Chen, Zheng
    Gomaa, Ahmed
    Lockhart, Albert Craig
    Salaria, Safia
    Wang, Jialiang
    Lewis, Keeli B.
    Ecsedy, Jeffrey
    Washington, Kay
    Beauchamp, Robert Daniel
    El-Rifai, Wael
    GASTROENTEROLOGY, 2019, 156 (03) : 662 - +
  • [8] Regulation of Mumps Virus Replication and Transcription by Kinase RPS6KB1
    Briggs, Kelsey
    Wang, Leyi
    Nagashima, Kaito
    Zengel, James
    Tripp, Ralph A.
    He, Biao
    JOURNAL OF VIROLOGY, 2020, 94 (12)
  • [9] miR-5191 functions as a tumor suppressor by targeting RPS6KB1 in colorectal cancer
    An, Hyun-Ju
    Park, Misun
    Kim, Joon
    Han, Young-Hoon
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2019, 55 (04) : 960 - 972
  • [10] In-silico investigation of RPS6KB1 associated cancer inhibitor: a drug repurposing study
    Rajendrasozhan, Saravanan
    Ahmad, Irfan
    Rab, Safia Obaidur
    Alshahrani, Mohammad Y.
    Almuqri, Eman Abdullah
    Siddiqui, Jamshaid Ahmad
    Mushtaque, Md
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
12345